Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138541
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2005-08-27
Brief Title:
Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Sponsor:
Novartis
Organization:
Novartis